Ginna Gonzalez, ARNP

Ginna Gonzalez practices at UMiami Medicine - Neurology in Miami, Florida.

Ginna Gonzalez's NPI, 1811171531, was assigned on December 18, 2007. Ginna Gonzalez holds Florida license ARNP1800082.

Ginna Gonzalez's primary practice is UMiami Medicine - Neurology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-4951.

Ginna Gonzalez's primary practice is UMiami Medicine - Neurology in Miami, Florida. Ginna Gonzalez is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Ginna Gonzalez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ginna Gonzalez practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Ginna Gonzalez's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Ginna Gonzalez is licensed in Florida.

Dmand AI lists muscle disease and muscle weakness among the conditions Ginna Gonzalez treats.

CMS data shows 168 Medicare services from Ginna Gonzalez across 5 procedure codes in 2024, for 64 Medicare patients. Medicare paid $14,423 for them. Every service was in an office.

CMS counts 64 Medicare patients who saw Ginna Gonzalez in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ginna Gonzalez's median patient age at 65, with 45% women.

In 2024, Ginna Gonzalez wrote 1,126 Medicare Part D claims for 118 patients. 61% of them were for generic drugs. CMS names the drug for 1,036 of them, across 16 drugs with 11 or more claims each, at $4,024,914 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Ginna Gonzalez for performance year 2024, reported as part of a group. Ginna Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ginna Gonzalez as offering telehealth.

CMS Open Payments shows 18 general payments to Ginna Gonzalez from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $239.